Quality Use of Respiratory Medicines Group, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia.
Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
NPJ Prim Care Respir Med. 2019 Dec 5;29(1):43. doi: 10.1038/s41533-019-0156-4.
Factors related to the discrepancy between patient-perceived and actual disease control remain unclear. Identifying patients at risk of overestimation of asthma control remains elusive. This study aimed to (i) investigate the relationship between patient-reported and actual level of asthma control (ii), compare the characteristics between patients who believe their asthma is well controlled that accurately report 'well-controlled' asthma with those that do not, and (iii) identify factors associated with inaccurately reported 'well-controlled' asthma. A historical, multinational, cross-sectional study using data from the iHARP (initiative Helping Asthma in Real-life Patients) review service for adults with asthma prescribed fixed-dose combination therapy. Data from 4274 patients were analysed. A major discrepancy between patient-reported and Global Initiative for Asthma defined asthma control was detected; 71.1% of patients who reported 'well-controlled' asthma were inaccurate in their perception despite receiving regular maintenance therapy. Significant differences were noted in age, gender, body mass index, education level, medication use, side effects, attitudes to preventer inhaler use, inhaler technique review and respiratory specialist review between patients who accurately reported 'well-controlled' asthma and those who did not. Independent risk factors associated with inaccurately reported 'well-controlled' asthma were: having taken a maximum of 5-12 puffs or more of reliever inhaler on at least one day within the previous 4 weeks; being female; having seen a respiratory specialist more than a year ago (rather than in the previous year); and having required oral corticosteroids for worsening asthma in the previous year. The study highlighted the significant hidden burden associated with under-recognition of poor asthma control, on the part of the patient and the need for targeted interventions designed to address the continuing discrepancy between perceived and actual disease control.
患者感知的疾病控制与实际控制之间存在差异的相关因素尚不清楚。确定存在高估哮喘控制风险的患者仍然难以捉摸。本研究旨在:(i)研究患者报告的哮喘控制水平与实际水平之间的关系;(ii)比较那些准确报告“控制良好”哮喘但认为自己哮喘控制良好的患者与那些不准确报告的患者的特征;(iii)确定与不准确报告“控制良好”哮喘相关的因素。这是一项回顾性、多国、横断面研究,使用了 iHARP(帮助现实中哮喘患者的倡议)审查服务中接受固定剂量联合治疗的成年哮喘患者的数据。分析了 4274 名患者的数据。患者报告的哮喘控制与全球哮喘倡议定义的哮喘控制之间存在明显差异;尽管接受了常规维持治疗,但仍有 71.1%报告“控制良好”的患者对其感知不准确。在准确报告“控制良好”哮喘的患者和不准确报告的患者之间,在年龄、性别、体重指数、教育水平、药物使用、副作用、预防吸入器使用态度、吸入器技术审查和呼吸专科医生审查方面存在显著差异。与不准确报告“控制良好”哮喘相关的独立危险因素包括:在过去 4 周内至少有一天使用了最大剂量的 5-12 吸或更多的缓解吸入器;女性;一年多前(而不是去年)看过呼吸科专家;并且在过去一年中因哮喘恶化而需要口服皮质类固醇。这项研究强调了患者对哮喘控制不佳认识不足所带来的巨大隐藏负担,以及需要针对目标干预措施,以解决感知和实际疾病控制之间持续存在的差异。